IP Library Granted Patent US 10,208,305
Granted Patent B2
US 10,208,305 · App. 14/130,769 · Granted Feb 19, 2019

RNA-YY1 interactions

Inventors: Jeannie T. Lee (Boston, MA); Yesu Jeon (Cambridge, MA)
Assignee: The General Hospital Corporation
C12N15/1048C12N15/1072C12N15/1093G01N33/5011G01N33/574G01N33/57484G01N33/6872G01N2500/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,208,305
App. No.
14/130,769
Granted
Feb 19, 2019
Kind
B2
Abstract

Methods relating to obtaining libraries of YY1-binding long non-coding RNAs, libraries obtained thereby, and methods of use thereof.

Claims (10)

1. A method of identifying a compound that disrupts binding of a Yin-Yang 1 (YY1)-binding long non-coding RNA (lncRNA) to Yin-Yang 1 (YY1) protein, the method comprising:

(a) identifying an lncRNA that binds YY1 protein;

(b) providing a cell-free sample comprising a YY1-binding lncRNA and YY1 protein, wherein the YY1-binding lncRNA binds to the YY1 protein thereby forming lncRNA-YY1 protein complexes;

(c) contacting the cell-free sample with a test compound, wherein the test compound is a nucleic acid targeting the YY1-binding lncRNA;

(d) isolating the lncRNA-YY1 protein complexes from the cell-free sample by contacting the cell-free sample comprising the lncRNA-YY1 protein complexes with an anti-YY1 antibody, wherein the anti-YY1 antibody specifically binds to YY1 protein, and immunoprecipitating the lncRNA-YY1 protein complexes; and

(e) detecting formation of the lncRNA-YY1 protein complexes in presence and absence of the test compound, wherein a decrease in formation of lncRNA-YY1 protein complexes in the presence of the test compound as compared to formation of lncRNA-YY1 protein complexes in the absence of test compound indicates that the test compound disrupts the binding of the YY1-binding lncRNA to the YY1 protein.

2. The method of claim 1 , wherein the YY1 protein is labeled.

3. The method of claim 1 , further comprising wherein the YY1 protein not bound to YY1-binding lncRNA is isolated from the cell-free sample.

4. The method of claim 1 , wherein the YY1-binding lncRNA is labeled.

5. The method of claim 1 , wherein both the YY1 protein and the YY1-binding lncRNA are labeled.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 20, 2015
From: MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036131/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2014
From: LEE, JEANNIE T.; HOWARD HUGHES MEDICAL INSTITUTE
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 032578/0606 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2014
From: JEON, YESU
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 032578/0619 →
Continuity (2)
Provisional Application 61504660 · Jul 5, 2011
Related Publication 20140213460A1 · Jul 31, 2014